349 related articles for article (PubMed ID: 9225682)
21. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
22. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
[TBL] [Abstract][Full Text] [Related]
23. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues.
Kuroki S; Saida T; Nukina M; Haruta T; Yoshioka M; Kobayashi Y; Nakanishi H
Ann Neurol; 1993 Mar; 33(3):243-7. PubMed ID: 8498807
[TBL] [Abstract][Full Text] [Related]
24. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
Yuki N; Miyatake T
Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
[TBL] [Abstract][Full Text] [Related]
25. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
26. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
[TBL] [Abstract][Full Text] [Related]
27. Campylobacter jejuni infection and Guillain-Barré syndrome.
Rees JH; Soudain SE; Gregson NA; Hughes RA
N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
Takahashi M; Koga M; Yokoyama K; Yuki N
J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
[TBL] [Abstract][Full Text] [Related]
29. Guillain-Barré and Fisher's syndromes subsequent to Campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies.
Koga M; Yuki N; Kashiwase K; Tadokoro K; Juji T; Hirata K
J Neuroimmunol; 1998 Aug; 88(1-2):62-6. PubMed ID: 9688325
[TBL] [Abstract][Full Text] [Related]
30. [Guillain-Barré syndrome and Fisher syndrome].
Kusunoki S; Kanazawa I
Nihon Rinsho; 1997 Apr; 55(4):940-4. PubMed ID: 9103898
[TBL] [Abstract][Full Text] [Related]
31. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
[TBL] [Abstract][Full Text] [Related]
32. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome.
Yuki N
J Neurochem; 2007 Nov; 103 Suppl 1():150-8. PubMed ID: 17986150
[TBL] [Abstract][Full Text] [Related]
33. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome.
Yuki N; Taki T; Takahashi M; Saito K; Yoshino H; Tai T; Handa S; Miyatake T
Ann Neurol; 1994 Nov; 36(5):791-3. PubMed ID: 7526777
[TBL] [Abstract][Full Text] [Related]
34. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
36. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
[TBL] [Abstract][Full Text] [Related]
37. [Campylobacter genes responsible for the development and determinant of clinical features of Guillain-Barré syndrome].
Yuki N
Nihon Rinsho; 2008 Jun; 66(6):1205-10. PubMed ID: 18540372
[TBL] [Abstract][Full Text] [Related]
38. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
[TBL] [Abstract][Full Text] [Related]
39. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
[TBL] [Abstract][Full Text] [Related]
40. [Guillain-Barré syndrome associated Campylobacter jejuni serogroup Penner A showing antecedent fever and abdominal pain without diarrhea].
Fukushima T; Yukawa T; Makino K; Matsubara N; Yamazaki M
No To Shinkei; 2005 Oct; 57(10):889-92. PubMed ID: 16277234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]